alpha-aminopyridine has been researched along with Cancer of Nose in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, B; Chen, J; Jiang, C; Lv, C; Wang, J; Xu, J; Xu, X | 1 |
1 other study(ies) available for alpha-aminopyridine and Cancer of Nose
Article | Year |
---|---|
Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.
Topics: Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Histone Deacetylase Inhibitors; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms; Programmed Cell Death 1 Receptor; Remission Induction; Treatment Outcome | 2021 |